Hemostatic treatment in the early stage of intracerebral hemorrhage: The recombinant factor VIIa experience

Stroke

Volumn 36, Issue 10, 2005, Pages 2321-2322

  Kase, Carlos S ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOSTATIC AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; WARFARIN;

BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HUMAN; MORTALITY; PRIORITY JOURNAL; RANKIN SCALE; RISK REDUCTION; SHORT SURVEY; SURGICAL DRAINAGE; SYMPTOMATOLOGY; THROMBOEMBOLISM; TREATMENT OUTCOME;

CEREBRAL HEMORRHAGE; CLINICAL TRIALS; FACTOR VIIA; HEMOSTATIC TECHNIQUES; HEMOSTATICS; HUMANS; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 26444561833     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000179041.80222.dc     Document Type: Short Survey

References (17)

1. Poungvarin N, Bhoopat W, Viriyavejakul A, Rodprasert P, Buranasiri P, Sukondhabhant S, Hensley MJ, Strom BL. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med. 1987;316:1229-1233.
2. Yu YL, Kumana CR, Lauder IJ, Cheung YK, Chan FL, Kou M, Fong KY, Cheung RT, Chang CM. Treatment of acute cerebral hemorrhage with intravenous glycerol: a double-blind, placebo-controlled, randomized trial Stroke. 1992;23:967-971.
3. Fernandes HM, Gregson B, Siddique S, Mendelow AD. Surgery in intracerebral hemorrhage: the uncertainty continues. Stroke. 2000;31:2511-2516.
4. Morgenstern LB, Frankowski RF, Shedden P, Pasteur W, Grotta JC. Surgical treatment for intracerebral hemorrhage (STICH): a single-center randomized clinical trial. Neurology. 1998;51:1359-1363.
5. Zuccarello M, Brott T, Derex L, Kothari R, Sauerbeck L, Tew J, Van Loveren H, Yeh HS, Tomsick T, Pancioli A, Khoury J, Broderick J. Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke. 1999;30:1833-1839.
6. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, Karimi A, Shaw MD, Barer DH; STICH Investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387-397.
7. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777-785.
8. NovoSeven (package insert). Princeton, NJ: Novo Nordisk Pharmaceuticals, Inc; 2003.
9. Freeman WD, Brott TG, Barrett KM, Castillo PR, Deen HG, Czervionke LF, Meschia JF. Recombinant factor Vila for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc. 2004;79:1495-1500.
10. Bertram M, Bonsanto M, Hacke W, Schwab S. Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J Neurol. 2000;247:209-214.
11. Brown DL, Morgenstern LB. Stopping the bleeding in intracerebral hemorrhage [Editorial]. N Engl J Med. 2005;352:828-830
12. Qureshi AI, Bliwise DL, Bliwise NG, Akbar MS, Uzen G, Frankel MR. Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit Care Med. 1999;27:480-485.
13. Mayer SA, Brun NC. Recombinant activated factor VII for acute intra-cerebral hemorrhage [Letter]. N Engl J Med. 2005;352:2134.
14. Monroe DM, Hoffman M, Oliver JA, Roberts HR. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol. 1997;99:542-547.
15. Xi G, Wagner KR, Keep RF, Hua Y, de Courten-Myers GM, Broderick JP, Brott TG, Hoff JT, Muizelaar JP. Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke. 1998;29:2580-2586.
16. Castillo J, Davalos A, Alvarez-Sabin J, Pumar JM, Leira R, Silva Y, Montaner J, Kase CS. Molecular signatures of brain injury after intracerebral hemorrhage. Neurology. 2002;58:624-629.
17. Mayer SA, Brun NC, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T, Europe Austral/Asia NovoSeven ICH Trial Investigators. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke. 2005;36:74-79.